EAM
VIRX
Eventide Asset Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-5,965,455
| Closed | -$7.25M | – | 133 |
|
|
2019
Q1 | $7.25M | Buy |
5,965,455
+3,700,000
| +163% | +$4.5M | 0.25% | 81 |
|
|
2018
Q4 | $942K | Hold |
2,265,455
| – | – | 0.04% | 119 |
|
|
2018
Q3 | $4.53M | Hold |
2,265,455
| – | – | 0.17% | 100 |
|
|
2018
Q2 | $4.8M | Hold |
2,265,455
| – | – | 0.2% | 95 |
|
|
2018
Q1 | $6.16M | Hold |
2,265,455
| – | – | 0.29% | 85 |
|
|
2017
Q4 | $8.36M | Buy |
2,265,455
+2,252,356
| +17,195% | +$8.31M | 0.44% | 64 |
|
|
2017
Q3 | $25K | Buy |
+13,099
| New | +$25K | ﹤0.01% | 136 |
|
|
2014
Q4 | – | Sell |
-91,800
| Closed | -$655K | – | 109 |
|
|
2014
Q3 | $655K | Hold |
91,800
| – | – | 0.09% | 99 |
|
|
2014
Q2 | $599K | Hold |
91,800
| – | – | 0.08% | 101 |
|
|
2014
Q1 | $607K | Hold |
91,800
| – | – | 0.09% | 97 |
|
|
2013
Q4 | $435K | Buy |
+91,800
| New | +$435K | 0.13% | 89 |
|